FRIDAY JULY 8TH, 2011

08:45 – 09:00 Welcome by Organisers

Session I

09:00 – 09:15  Rhegmatogenous retinal detachment: reasons for reduced vision after anatomically successful surgery

Chalkia Aikaterini, Tsika Chrysanthi, Charissis Spyridon K, Agorogiannis George I, Tsilimbaris Miltiadis K

 

09:15 – 09:30 Surgical and visual outcome after multiple operations for recurrent retinal detachment surgery

Tsika Chrysanthi, Tsilimbaris Miltiadis K, Petropoulos I, Bronzou Katerina, Pournaras Constantin

 

09:30 – 09:45 Long term anatomic and functional results after pneumatic retinopexy for the management of rhegmatogenous retinal detachment

Grammenandi A., Portaliou D, Tsolakis N. , Spanos T. , Dourdoureka A., Vatsis K. , Kourenti C , Feretis E.

 

09:45 – 10:00  Pneumatic retinopexy in optic nerve pit and serous macular detachment

Veronika Aslanova, MD 

 

10:00 – 10:15 Massage on large macular holes

George Pappas

10:15 – 10:30 Why the retina breaks and the ILM remain intact in macula holes? An answer with broad implications

 IP Theocharis 

 

10:30 – 10:45 Vitreoretinal Interface in macular diseases

Maria Stefaniotou

 

10:45 – 11:00 Reversal of retinal capillary non-perfusion in diabetes and venous occlusions

Thomas R Friberg, Andrew Eller, Peter Brennen 

 

11:00 – 11:15   The contribution of SOCT Copernicus HR to age-related macula degeneration imaging

C. Kalogeropoulos, K. Malamos, E. Christodoulou, P. Zafeiropoulos, I. Koumpoulis, M. Aspiotis 

 

11:15 – 11:30 Simultaneous  assessment of diabetic corneal neuropathy and retinopathy

Eirini Nitoda, P. Kallinikos, A. Pallikaris, Ε. Ganotakis, G. Amoiridis, M. K. Tsilimbaris

 

11:30 – 12:00  Coffee Break

Session II       

12:00 – 12:15  Steroids update in Macular Edema

Anat Loewenstein

 

12:15 – 12:30  Pharmacokinetics of intravitreal avastin and lucentis after vitrectomy and lensectomy

John B. Christoforidis MD, George H. Hinkle RPh,  Michelle C. Carlton, MS, Angela Jiang, MS, Jillian Wang, BS, Cedric Pratt, DO, Michael V. Knopp, MD, PhD

 

12:30 – 12:45  Association of ranibizumab (Lucentis) or bevacizumab (Avastin) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment.

C. J. Pournaras MD, M. Veurink, C. Stella, C. Tabatabay, R. Gurny 

 

12:45 – 13:00  Intravitreal Combination of Bevacizumab and Triamcinolone Injection for Treatment of Refractory Macular Edema

                        Burak ERDEN, Murat ASLANKURT, Mustafa ELÇİOĞLU ,Osman ÇEKİÇ      

13:00 – 13:15  The Effect of Bevacizumab on Fibroangiogenic Growth Factors in Proliferative Diabetic Retinopathy: A Prospective, Randomized, Double-masked, Controlled Study.

Dean Eliott MD, Elliott Sohn, Leo Kim, Hani Salehi-Had, Michael Javaheri, Shikun He, David Hinton 

 

13:15 – 13:30 Switching from bevacizumab to ranibizumab or vice versa in the treatment of choroidal neovascularization due to age-related macular degeneration

Murat Aslankurt, MD, Burak Erden, MD, Mustafa Elcioglu, MD, Osman Cekic,MD, PhD

 

13:30 – 13:45  Does oral zeazanthin improve the anatomic and visual outcome of Triple Therapy for Subfoveal Choroidal Neovascularization (CNV) in Age-Related Macular Degeneration

R. Joseph Olk, MD, Samir Sayegh, MD, Enrique Peralta, MD,  Dennis Gerhardt, PHD

 

13:45 – 14:00  Intravitreal Bevacizumab Treatment for a Sorsby’s Macular Distrophy- Case Report

Burak ERDEN, Murat ASLANKURT, Mustafa ELÇİOĞLU, Osman ÇEKİÇ

 

14:00 – 14:15  Ranimizumab in Retinal Vein Occlusion

George Pappas

 

14:15 – 14:30  Effect of anti-VEGF drugs and steroids on the inner blood-retinal barrier, after experimental BRVO in rats: preliminary results

P.Bouzika, N.Gilodi, A.Conti , M.Tsilimbaris, C.J.Pournaras

 

14:30 – 14:45  Fluorescein Angiography Guided Photodynamic Therapy in Severe Chronic Central Serous Chorioretinopathy: Long - Term Results

Tsakonas G, Kotsolis A, Rouvas A, Koutsandrea C, Georgalas I, Krassas A, Douvali M, Ladas ID

 

14:45 – 15:00  12 months follow up results after low fluence photodynamic therapy (PDT-LF) in 25 patients with recurrent central serous chorioretinopathy (CSR)

Diamanti Ramza Anastasia MD, Datseris Ioannis, Diamanti Ramza Anastasia, Rouvas Alexandros, Labrinakis Ioannis, Micha Maria, Chaidoulis Stylianos 

 

 

 

SATURDAY JULY 9^TH, 2011

Session III

08:30 – 08:45  Glaucoma after scleral buckling surgery

Petros E. Carvounis, M.D., F.R.C.S.C., Usha Pinninti, M.D.

 

08:45 – 09:00  Transconjunctival sutureless vitrectomy as compared to standard 20g vitrectomy for epiretinal membranes: Visual outcomes and complications.

E. Mendrinos MD, A. Shadi, A. Mateo-Montoya, C.J. Pournaras

 

09:00 – 09:15  Safety of 20-gauge transconjunctival sutureless vitrectomy

Papaefthymiou Ioannis MD, Mangioris Georgios, Mendrinos Efstratios, C.J.Pournaras

 

09:15 – 09:30  25-gauge vitrectomy techniques in ocular trauma

Periklis Brazitikos, Sofia Androudi

 

09:30 – 09:45  Early vitrectomy for vitreous diabetic haemmorage in 25+ G surgery

A. Papadopoulou, E. Fandel, K. Nikolakopoulos, K. Bikos, A. Nikolakopoulos

 

09:45 – 10:00  Phaco fragmantation, and no use of IOL in PVR cases that treated with 25+G vitrectomy and silicone oil.

Efstratios Gotzaridis

 

10:00 – 10:15  Silicone oil  5.700 cts injected from 25 g cannulas in complicated  Bimanual Retina Surgery

A. Nikolakopoulos,  A. Papadopoulou, I. Panidou, T. Panakleridou, K. Nikolakopoulos, K. Bikos

 

10:15 – 10:30  Removal of a shot gun pallet using 25 G surgery

 A.Nikolakopoulos, E Fandel, A Papadopoulou, K Nikolakopouos, K Bikos

 

10:30 – 10:45  Advanced posterior and anterior surgery with a dedicated platform

Giorgio Santin MD, Roberto Bellucci, Rachele Pizzi

 

10:45 – 11:00  Pars Plana Vitrectomy and Heavy Silicon Oil Tamponade for İnferior Retinal Detachment

Murat Aslankurt, MD, Burak Erden, MD, Mustafa Elcioglu, MD, Osman Cekic, MD, PhD

 

11:00 – 11:15  Incomplete drain of subretinal fluid, during vitrectomy for retinal detachment

Efstratios Gotzaridis

 

11:15 – 11:30  Sequential epiretinal membrane removal: Internal Limiting Membrane Pattern.

 C. J. Pournaras MD, M. L. Bochaton-Piallat, N. Gilodi, E. Mendrinos

11:30 – 12:00  Coffee Break

Session IV

12:00 – 12:15 Optic Nerve Damage after Irradiation of Intraocular Tumors

Evangelos S. Gragoudas, Anne Marie Lane, Ivana Kim

 

12:15 – 12:30  Choroidal and retinal ischemia before and after irradiation treatment of uveal melanomas.  A Panoramic ICG and fluorescein angiography study.

Leonidas Zografos, MD , Ann Schalenbourg, MD

 

12:30 – 12:45  Ranibizumab in Combination with Proton Beam Irradiation for Choroidal Melanoma: One-Year Results

Ivana K. Kim, Anne Marie Lane, Evangelos S. Gragoudas

 

12:45 – 13:00  Genotype-Dependent Sensitivity Of Ocular Melanoma Cell Lines To Inhibitors Of Kinases, Including BRAF, MEK And Akt: Rationale For Personalized Therapy.

Vasiliki Poulaki MD , PHD, Nicholas Mitsiades, Bin He, Sue Anne Chew

 

13:00 – 13:15  AICAR an exercise mimetic as novel anti cancer agent for intraocular tumours

Demetrios Vavvas MD , PHD, Sofia Theodoropoulou, Thanos Papakostas, Maki Kayama, Joan W iller, Bruce Ksander, Evangelos Gragoudas

 

13:15 – 13:30  Retinal metastasis of small cell lung carcinoma, two case reports

Lavric Alenka MD, Vidovič Valentinčič N, Globočnik Petrovič M, Kloboves Prevodnik V, Novak Andrejčič K

 

13:30 – 13:45  Safety testing of epimacular brachytherapy using microperimetry and ICG angiography

Alexandros N. Stangos MD, Robert Petrarca, Matthew Richardson, Timothy L. Jackson

 

13:45 – 14:00  RIP kinase-mediated necrosis as an alternative mechanism of cell death in retinal degeneration

Yusuke Murakami MD , PHD,  George Trichonas, Joan W. Miller, Demetrios G. Vavvas

 

14:00 – 14:15  Edaravone, a ROS scavenger, ameliorates photoreceptor apoptosis after experimental retinal detachment

Miin Roh, Yusuke Murakami, Aristomenis Thanos,Demetrios  Vavvas, and Joan W. Miller

 

14:15 – 14:30  DHEA Analogue Neuroprotection in an Experimental Model of Retinal Detachment

Pavlina A. Tsoka, Ioannis Charalampopoulos, Achilles Gravanis, Miltiadis K. Tsilimbaris

 

14:30 – 14:45  Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors From Cell Death After Experimental Retinal Detachment

Dimosthenis Mantopoulos, Yusuke Murakami Jason Comander, Aristomenis Thanos, Miin Roh, Joan Miller, Demetrios Vavvas

14:45 – 15:00  Analysis of gene expression in acute ischemic neuroretinas: a genome-wide screen discriminating occlusion (BRVO) versus laser effects in rats.

A. Geka, C. Pournaras, C. Oropesa, O. Schaad, A. Conti, C.J. Pournaras

 

 

 

 

 

SUNDAY JULY 10^th, 2011

Session V

09:00 – 09:15 Infrared scanning laser ophthalmoscope imaging of the macula and its correlation with functional loss and structural changes in patients with stargardt disease. 

A.Anastasakis MD,  Fishman GA, Lindeman M

 

09:15 – 09:30 Phenotyping of Greek patients with Stadtgadt disease

Miltiadis K. Tsilimbaris, Plainis S ,Anastasakis A, Tsika C ,Douka H, Kamakari S.

09:30 – 09:45 Mutation spectrum of the ABCA4 gene in Greek patients with stargardt disease: identification of a novel mutation and evidence of three prevalent mutated alleles

Kamakari S., Stamatiou P., Panagiotoglou T., Tsika C., Anagnou NP., Datseris I., Tsilimbaris M

 

09:45 – 10:00 Educational levels in patients with Stargardt disease

A.Anastasakis MD, Thobani Azzrah, Fishman A. Gerald

 

10:00 – 10:15  Genotype-Phenotype Correlations in the Bardet-Biedl Syndrome

Anthony B. Daniels MD, Michael A. Sandberg, Jianjun Chen, Terri L. McGee, Carol Weigel-DiFranco, J. Fielding Hejtmancik, Eliot L. Berson 

 

10:15 – 10:30  Sequence variation in the CX3CR1 gene is associated with advanced age-related macular degeneration in a Greek population

E. Anastasopoulos, A. Kakoulidou, AL. Coleman, J Sinsheimer, MR. Wilson, Fei Yu PhD, Aggeliki Salonikiou, P. Founti, A. Lambropoulos,  F. Topouzis

 

10:30 – 11:00  Coffee Break

 

Session VI

11:00 – 11:15  The Eye is Moving! Sclera Deformation by the Ocular Movements and its Role on the Development of the Clinical Signs of various Macula Disorders. A new Hypothesis.

Ioannis P Theocharis MD

 

11:15 – 11:30  20-gauge transconjunctival sutureless vitrectomy does not induce astigmatism

Mendrinos Efstratios, Mangioris Georgios, Mendrinos Efstratios, Hafezi Farhad, Pournaras CJ

 

11:30 – 11:45 Retinal bioavailability of a DHEA synthetic analog after intraperitoneal administration in the Sprague Dawley rat.

Tsika C, Tsoka P, Tzatzarakis M, Charalambopoulos I, Tsilimbaris MK 

 

11:45 – 12:00  Legal blindness in Rethymnon: two years prevalence

Christodoulakis Ev, Chliveros K.,  Vrachnidis ST., Godolias ST

 

12:00 – 12:15  Contrast adaptation reveals orientation and spatial frequency selectivity in the visual system; a Reaction Time study.

                        Plainis S, Parry NRA, Sapountzis P, Murray IJ

Plainis S, Parry NRA, Sapountzis P, Murray IJ

 

12:15 – 12:30  On the role of retinal diffusion and spectral reflectance of the fundus in Optical metrology in the human eye

Charilaos Ginis

12:30 – 12:45  A novel device for the measurement of intraocular pressure, ocular rigidity and pulsatile blood flow

N.G. Karyotakis, H.S. Ginis, M.K. Tsilimbaris, E.M Siggelaki, I.G. Pallikaris